Bio-Thera signs US deal with Intas for golimumab biosimilar
Pharmaceutical Technology
FEBRUARY 11, 2025
Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in the US.
Pharmaceutical Technology
FEBRUARY 11, 2025
Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in the US.
pharmaphorum
FEBRUARY 11, 2025
A US judge has imposed a temporary injunction in 22 US states on the Trump administration's sweeping cuts to NIH funding of medical research
Pharmaceutical Technology
FEBRUARY 11, 2025
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.
Let's personalize your content